terazosin has been researched along with Bladder Cancer in 1 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tahmatzopoulos, A | 1 |
| Lagrange, CA | 1 |
| Zeng, L | 1 |
| Mitchell, BL | 1 |
| Conner, WT | 1 |
| Kyprianou, N | 1 |
1 other study available for terazosin and Bladder Cancer
| Article | Year |
|---|---|
Effect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Carcinoma, | 2005 |